For a healthy heart, the best breakfast is one that provides 20% to 30% of daily calorie intake, while wating either less or ...

India is facing an alarming rise in metabolic syndrome, which is associated with Type-2 diabetes and other severe health ...

Carrying excess weight around the waist can be a predictor of chronic disease, and men may be at risk more than women ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

A recent study from Johns Hopkins Medicine has found that a drug originally developed to treat Alzheimer’s disease, ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

The study highlighted interventions to reduce heart failure risk — most notably hypertension control and weight loss.

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...